Evidence map›Paper›PMID 18588681›Full record

ArticleBreast cancer research : BCR2008

PMC42, a breast progenitor cancer cell line, has normal-like mRNA and microRNA transcriptomes.

Anna Git, Inmaculada Spiteri, Cherie Blenkiron, Mark J Dunning, Jessica C M Pole, Suet-Feung Chin, Yanzhong Wang, James Smith, Frederick J Livesey, Carlos Caldas

Open access · goldAbstract read
In one paragraph

Article in Breast cancer research : BCR, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. miRNA clusters as therapeutic targets for hormone-resistant breast cancer.Expert review of endocrinology & metabolism · 2015
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Systems biology and genomics of breast cancer.Cold Spring Harbor perspectives in biology · 2011
    Review
  10. Article
  11. Micro-RNAs and breast cancer.Molecular oncology · 2010
    Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Anna GitDepartment of Oncology, Breast Cancer Functional Genomics Laboratory, Cancer Research UK Cambridge Research Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. Anna.Git@cancer.org.uk
Inmaculada Spiteri
Cherie Blenkiron
Mark J Dunning
Jessica C M Pole
Suet-Feung Chin
Yanzhong Wang
James Smith
Frederick J Livesey
Carlos Caldas
University of Cambridge · GBCancer Research UK · GBHutchison/MRC Research Centre · GBWellcome/Cancer Research UK Gurdon Institute · GB

Funding

Biotechnology and Biological Sciences Research CouncilCancer Research UKWellcome Trust
6 · The paper itself

Abstract

introductionThe use of cultured cell lines as model systems for normal tissue is limited by the molecular alterations accompanying the immortalisation process, including changes in the mRNA and microRNA (miRNA) repertoire. Therefore, identification of cell lines with normal-like expression profiles is of paramount importance in studies of normal gene regulation.

methodsThe mRNA and miRNA expression profiles of several breast cell lines of cancerous or normal origin were measured using printed slide arrays, Luminex bead arrays, and real-time reverse transcription-polymerase chain reaction.

resultsWe demonstrate that the mRNA expression profiles of two breast cell lines are similar to that of normal breast tissue: HB4a, immortalised normal breast epithelium, and PMC42, a breast cancer cell line that retains progenitor pluripotency allowing in-culture differentiation to both secretory and myoepithelial fates. In contrast, only PMC42 exhibits a normal-like miRNA expression profile. We identified a group of miRNAs that are highly expressed in normal breast tissue and PMC42 but are lost in all other cancerous and normal-origin breast cell lines and observed a similar loss in immortalised lymphoblastoid cell lines compared with healthy uncultured B cells. Moreover, like tumour suppressor genes, these miRNAs are lost in a variety of tumours. We show that the mechanism leading to the loss of these miRNAs in breast cancer cell lines has genomic, transcriptional, and post-transcriptional components.

conclusionWe propose that, despite its neoplastic origin, PMC42 is an excellent molecular model for normal breast epithelium, providing a unique tool to study breast differentiation and the function of key miRNAs that are typically lost in cancer.

Indexed as

Cell Line, TumorGene Expression ProfilingMicroRNAsBreast NeoplasmsCell Culture TechniquesGene Expression Regulation, NeoplasticHumansNucleic Acid HybridizationOligonucleotidesReverse Transcriptase Polymerase Chain ReactionRNA, MessengerRNA, NeoplasmRNA, TransferTranscription, GeneticMicroRNAsOligonucleotidesRNA, MessengerRNA, NeoplasmRNA, Transfer

Identifiers

PMID18588681
PMCPMC2481505
OpenAlexW2043944733

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.